Paper39728367
New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.
Niño-Vega GA and 2 others. J Fungi (Basel), 2024. Cited by 17 papers, by iCite.
Cite this record
ConductScience Library. New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions. Papers, record 39728367. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39728367
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- New Ground in Antifungal Discovery and Therapy for Invasive Fungal Infections: Innovations, Challenges, and Future Directions.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References107
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 28597822 | Fungi that Infect Humans. | Microbiol Spectr | 2017 | https://conductscience.org/library/papers/28597822 | PubMed |
| 2 | 26160833 | Development and Application of a High-Throughput Screening Method to Evaluate Antifungal Activity against Trichophyton tonsurans. | J Biomol Screen | 2015 | https://conductscience.org/library/papers/26160833 | PubMed |
| 3 | 32849347 | Silver Nanoantibiotics Display Strong Antifungal Activity Against the Emergent Multidrug-Resistant Yeast Candida auris Under Both Planktonic and Biofilm Growing Conditions. | Front Microbiol | 2020 | https://conductscience.org/library/papers/32849347 | PubMed |
| 4 | 29208749 | Development of Anti-Virulence Approaches for Candidiasis via a Novel Series of Small-Molecule Inhibitors of Candida albicans Filamentation. | mBio | 2017 | https://conductscience.org/library/papers/29208749 | PubMed |
| 5 | 39195465 | Recent Advances in Marine-Derived Compounds as Potent Antibacterial and Antifungal Agents: A Comprehensive Review. | Mar Drugs | 2024 | https://conductscience.org/library/papers/39195465 | PubMed |
| 6 | 38807795 | Fosmanogepix: The Novel Anti-Fungal Agent's Comprehensive Review of in Vitro, in Vivo, and Current Insights From Advancing Clinical Trials. | Cureus | 2024 | https://conductscience.org/library/papers/38807795 | PubMed |
| 7 | 29555634 | Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata. | Antimicrob Agents Chemother | 2018 | https://conductscience.org/library/papers/29555634 | PubMed |
| 8 | 35069463 | Antibiofilm Activities of Biogenic Silver Nanoparticles Against Candida albicans. | Front Microbiol | 2021 | https://conductscience.org/library/papers/35069463 | PubMed |
| 9 | 8457977 | Compounds active against cell walls of medically important fungi. | Clin Microbiol Rev | 1993 | https://conductscience.org/library/papers/8457977 | PubMed |
| 10 | 31611349 | Evaluation of Resistance Development to the Gwt1 Inhibitor Manogepix (APX001A) in Candida Species. | Antimicrob Agents Chemother | 2019 | https://conductscience.org/library/papers/31611349 | PubMed |
| 11 | 28069658 | SCY-078 Is Fungicidal against Candida Species in Time-Kill Studies. | Antimicrob Agents Chemother | 2017 | https://conductscience.org/library/papers/28069658 | PubMed |
| 12 | 22271309 | Molecular basis for fungicidal action of neothyonidioside, a triterpene glycoside from the sea cucumber, Australostichopus mollis. | Mol Biosyst | 2012 | https://conductscience.org/library/papers/22271309 | PubMed |
| 13 | 36257999 | Antifungal activity and genomic characterization of the biocontrol agent Bacillus velezensis CMRP 4489. | Sci Rep | 2022 | https://conductscience.org/library/papers/36257999 | PubMed |
| 14 | 34209118 | Niclosamide Is Active In Vitro against Mycetoma Pathogens. | Molecules | 2021 | https://conductscience.org/library/papers/34209118 | PubMed |
| 15 | 37894800 | Design, Synthesis, and Biological Evaluation of N'-Phenylhydrazides as Potential Antifungal Agents. | Int J Mol Sci | 2023 | https://conductscience.org/library/papers/37894800 | PubMed |
| 16 | 32722455 | Current Antimycotics, New Prospects, and Future Approaches to Antifungal Therapy. | Antibiotics (Basel) | 2020 | https://conductscience.org/library/papers/32722455 | PubMed |
| 17 | 31818813 | Fosmanogepix (APX001) Is Effective in the Treatment of Immunocompromised Mice Infected with Invasive Pulmonary Scedosporiosis or Disseminated Fusariosis. | Antimicrob Agents Chemother | 2020 | https://conductscience.org/library/papers/31818813 | PubMed |
| 18 | 28158577 | In vitro activity of the novel echinocandin CD101 at pH 7 and 4 against Candida spp. isolates from patients with vulvovaginal candidiasis. | J Antimicrob Chemother | 2017 | https://conductscience.org/library/papers/28158577 | PubMed |
| 19 | 34001513 | In Vitro pH Activity of Ibrexafungerp against Fluconazole-Susceptible and -Resistant Candida Isolates from Women with Vulvovaginal Candidiasis. | Antimicrob Agents Chemother | 2021 | https://conductscience.org/library/papers/34001513 | PubMed |
| 20 | 30976107 | Applications of machine learning in drug discovery and development. | Nat Rev Drug Discov | 2019 | https://conductscience.org/library/papers/30976107 | PubMed |
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 17 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42930693 | Advances in Azole Antifungal Agents: From Structural Foundations to Resistance Challenges. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42930693 | PubMed |
| 42733675 | Pathogenesis and Triazole Resistance in Aspergillus fumigatus: A Narrative Review Across the Host Immune Spectrum and One Health Context. | Infect Drug Resist | 2026 | https://conductscience.org/library/papers/42733675 | PubMed |
| 42653695 | Pyrrolidine-Based Antifungal Agents Against Candida Species: A Systematic Review of Structure-Activity Relationships and Mechanistic Insights from Experimental Studies. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653695 | PubMed |
| 42346544 | Heat Shock Proteins in Medically Relevant Fungal Pathogens: From Molecular Chaperones to Virulence Factors and Therapeutic Targets. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/42346544 | PubMed |
| 41893109 | In Vitro Modeling of Mycelium Biomass Growth Kinetics of the Novel Fungicolous Species Xylaria karsticola NBIMCC 9097, with Insights into Its Antimicrobial Potential. | J Fungi (Basel) | 2026 | https://conductscience.org/library/papers/41893109 | PubMed |
| 41835000 | Structural barriers to antifungal drug development. | Front Cell Infect Microbiol | 2026 | https://conductscience.org/library/papers/41835000 | PubMed |
| 41590420 | From the Ground to the Clinic: The Evolution and Adaptation of Fungi. | J Fungi (Basel) | 2025 | https://conductscience.org/library/papers/41590420 | PubMed |
| 41545875 | Antifungal activity of oily core PEGylated PLGA nanocapsules loaded with Penicillium oxalicum fungal extract: in vitro, in vivo, and in silico study. | Microb Cell Fact | 2026 | https://conductscience.org/library/papers/41545875 | PubMed |
| 41149925 | Candida krusei Empyema: A Lung Transplant Case and Systematic Review of the Literature. | J Fungi (Basel) | 2025 | https://conductscience.org/library/papers/41149925 | PubMed |
| 40957969 | Fungal infections in focus: accelerating non-invasive imaging from preclinical insights to clinical breakthroughs. | Npj Imaging | 2025 | https://conductscience.org/library/papers/40957969 | PubMed |
| 40869230 | Exploring a Therapeutic Gold Mine: The Antifungal Potential of the Gold-Based Antirheumatic Drug Auranofin. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40869230 | PubMed |
| 40261080 | In vitro activity of SF001: a next-generation polyene versus amphotericin B. | Antimicrob Agents Chemother | 2025 | https://conductscience.org/library/papers/40261080 | PubMed |
| 40076689 | Special Issue "Antifungal Drug Discovery: Progresses, Challenges, Opportunities". | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40076689 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39728367
GET https://conductscience.org/api/papers/v1/39728367/references?page=2